Patent · US Active

Patient control of therapy suspension

US10086202B2 · kind B2 · utility

6Cited by
15References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 17, 2014
Grant dateOct 2, 2018
Priority date
Expiry dateDec 28, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16H40/63
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An example of a method performed by an implantable medical device (IMD) to deliver a therapy to a patient may include delivering the therapy to the patient, detecting a trigger that is controlled by the patient or a caregiver to the patient, and determining if at least one feature of the IMD for responding to a trigger is enabled. The IMD may be configured to allow the patient or the caregiver to the patient to enable the at least one feature. The method may further include, when the at least one feature is enabled, automatically implementing the at least one enabled feature in response to the detected trigger, including automatically suspending the therapy in response to the detected trigger and automatically restoring the therapy after a defined period after the detected trigger.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.